Beneficiary 4: BAS

Universität Basel (BAS)

Scientist in Charge: Thomas Ward

The University of Basel has a long tradition of excellence in teaching and research (est. 1460, 7 faculties with > 12’000 students and > 3’000 researchers). Life Sciences and Nanotechnology are among the focus areas of the University of Basel. The University is integrated in the Basel Life Science hub and enjoys privileged contacts with world-leading companies including: Novartis, Roche, Actelion, etc.

The Artificial Metalloenzymes Laboratory, led by Prof. Ward, is focused on the study of artificial metalloenzymes with applications in bio-nanotechnology, white biotechnology and synthetic biology.